View Clinical Trial (Medical Research Study)
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism - NCT00633893-Rosario - 0013(Clinical Trial 208236)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Rosario |
|
Country:
|
|
Argentina |
|
|
|
| Conditions: |
|
Venous Thrombosis |
| Purpose: |
|
The purpose is to evaluate the effects of an investigational blood thinner, apixaban, in
preventing venous thromboembolic (VTE) recurrence or death in patients who have completed
their intended treatment for deep vein thrombosis (DVT) or pulmonary embolism (PE)
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Men and women ≥ 18 years of age;
- Clinical diagnosis of DVT or PE;
- Anticoagulant treatment completed
- No recurrence of VTE
Exclusion Criteria:
- Subjects with indications for long-term treatment with a vitamin K antagonist
- Active bleeding or high risk for serious bleeding
- Short life expectancy
- Uncontrolled high blood pressure
- Impaired kidney or liver function |
|
|
|
| Study is available at: |
|
Local Institution
Rosario
Argentina
Primary Contact:
For participation information at a USA site use a phone number below. For site information outside the USA please email:
Email: Clinical.Trials@bms.com |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|